Skip to content
Research Article Open access CC BY 4.0

Use of Elores™ in Guiding Successful Treatment of Ventilator Associated Pneumonia Due to Multi Drug Resistant Acinetobacter baumannii and Klebsiella pneumoniae

Ashish Gupta, Sunny Rupal

Journal of Advances in Medicine and Medical Research · pp. 1–6 · Published 9 Sep 2016

10.9734/BJMMR/2016/28546

Abstract

Introduction: Increased antimicrobial resistance of Acinetobacter baumannii (A. baumannii) and Klebsiella pneumoniae (K. pneumoniae), is of great concern worldwide. Management of Ventilator associated pneumonia (VAP) due to MDR poses a challenge for clinicians. Case Presentation: Here we are discussing a case of 47 year old male patient diagnosed with VAP due to A. baumannii and K. pneumoniae. Use of Elores™ (Ceftriaxone/Sulbactam/Disodium-edetate) as antibiotic for the treatment of VAP due to MDR pathogen K. pneumoniae and A. baumannii resulted in clinical cure of infection. Conclusion: Elores™ can be considered as a safe and efficacious antibiotic to treat MDR gram negative pathogens in VAP.

Ceftriaxone/Sulbactam/Disodium-edetate antibiotic resistance Acinetobacter baumannii Klebsiella pneumoniae CSE1034 ventilator associated pneumonia (VAP).

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.